Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .

Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study

NCT06948565 ·Status: RECRUITING

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis

NCT05956197 ·Status: UNKNOWN

Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal

NCT01059396 ·Status: COMPLETED ·Phase: PHASE4

Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

NCT06263816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Real-World Validation of a Prognostic Prediction Model for Patients With Acute Exacerbations of Chronic Liver Disease

NCT06181448 ·Status: NOT_YET_RECRUITING

Utility of Renal Biomarkers in Cirrhosis

NCT01217983 ·Status: COMPLETED

To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.

NCT02465619 ·Status: WITHDRAWN

MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis

NCT03438916 ·Status: COMPLETED

Phase Angle and Mortality in Patients With Cirrhosis

NCT02023177 ·Status: COMPLETED

Effect of Non-Selective Beta-Blockers on Outcomes in Cirrhosis Patients After Hospitalization: A Retrospective Cohort Using Target Trial Design

NCT06977685 ·Status: ACTIVE_NOT_RECRUITING

Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension

NCT01282385 ·Status: UNKNOWN ·Phase: PHASE4

Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation

NCT03005587 ·Status: WITHDRAWN

Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)

NCT03713606 ·Status: UNKNOWN

Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China

NCT03435406 ·Status: UNKNOWN

Recall of a Cohort of Subjects in the Mediterranean Area. Monitoring of Liver Diseases (NUTRIHEP 3).

NCT06931925 ·Status: NOT_YET_RECRUITING

Comparison of Nutritional Screening Tools in Liver Cirrhosis Patients

NCT04502719 ·Status: RECRUITING

Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study

NCT03056612 ·Status: COMPLETED

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

NCT05249374 ·Status: COMPLETED ·Phase: PHASE1

Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis

NCT00332904 ·Status: UNKNOWN ·Phase: PHASE4

Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites

NCT03451292 ·Status: COMPLETED ·Phase: PHASE3

HVPG for Rebleeding Risk Stratification

NCT01751191 ·Status: COMPLETED

Assessment of Nutritional Status of Patients With Liver Cirrhosis

NCT03242798 ·Status: COMPLETED

Unknown Cause of Acute Liver Failure

NCT02041637 ·Status: COMPLETED

A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients

NCT02356250 ·Status: WITHDRAWN

Platelet Indices in Decompensated Post Hepatitic Liver Cirrhosis

NCT04126447 ·Status: UNKNOWN